Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

AACR 2012 /
EGFR mutation unique to glioblastoma linked to lack of response

31st Mar - 4th Apr 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.04.12
Views: 3838
Rating:

Dr Ingo Mellinghoff - Memorial Sloan-Kettering Cancer Center, New York, USA

Dr Mellinghof presents on epidermal growth factor receptor mutations that occur in glioblastoma and how they differ from those that occur in lung cancers.  This finding, which was presented at the AACR 2012 Annual Meeting, may explain the lack of response to epidermal growth factor receptor inhibitors seen in glioblastoma.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation